期刊文献+

外周血单核细胞中肺炎衣原体特异性抗原的检测 被引量:15

Detection of Chlamydia pneumoniae Specific Antigen in the Peripheral Blood Mononuclear Cell
下载PDF
导出
摘要 目的 :肺炎衣原体 (Cpn)特异性抗原检测方法的建立及其应用。方法 :分离人外周血单核细胞 (PBMC) ,用直接免疫荧光 (DIF)检测PBMC中的Cpn特异性抗原 ,同时用间接微量免疫荧光 (MIF)检测Cpn抗体。结果 :颈动脉粥样硬化病人和正常人PBMC中Cpn特异性抗原检出阳性率分别为 6 2 %和 30 % (P <0 .0 1) ;血浆中CpnIgG的检出阳性率分别为 72 %和2 8% ,P值 <0 .0 0 1;血浆中CpnIgM的检出阳性率分别为 16 %和 12 % (P值 >0 .0 5 )。结论 :PBMC中的Cpn特异性抗原和血浆中Cpn -IgG的高检出率均见于颈动脉粥样硬化病人 ,但抗原的检测具有更大的临床意义。 Objective: The aim of the study was to develop the method of detecting Chlamydia pneumoniae (Cpn) specific antigen and its application. Methods: The human peripheral blood mononuclear cells (PBMC) were separated and their specific antigen (Ag) of Cpn were measured by direct immunofluorescence test, at the same time, plasma specific antibodies (IgG?IgM ) to Cpn were measured by microimmunofluorescence test. Results: Cpn-Ag positive rate was 62% (31/50) in carotid atherosclerosis patients and 30% (15/50) in normal control ( P <0.01).Cpn-IgG positive rate was 72% and 28% respectively ( P <0.001). Cpn -IgM positive rate was 16% and 12% respectively ( P >0.05). Conclusion: Cpn-Ag and Cpn -IgG are high positive rate in patients, but detection of Cpn-antigen has more clinical significance.
出处 《中国临床医学》 2002年第3期243-245,共3页 Chinese Journal of Clinical Medicine
关键词 特异性抗原 检测 肺炎衣原体 外周血单核细胞 直接免疫荧光 间接微量免疫荧光 Chlamydia pneumoniae Peripheral blood mononuclear cells Direct immunofluorescence microimmunofluorescence
  • 相关文献

参考文献11

  • 1[1]Heick A, Striver E. Chlamydia penumoniae - associated A DEM. Eur J Neurol, 2000,7(4) :435 ~438.
  • 2[2]Rubegni P, Marano MR, De Aloe G. et al. Sweet's syndrome and Chlamydia pneumoniae infection. J Am Acad Dermatol,2001, 44(5) :862~864.
  • 3[3]Bodetti TJ, Timms P. Detection of Chlamydia pneumoniae DNA and antigen in the circulating mononuclear cell fractions of hu mans and koalas. Infect Immun, 2000, 68(5) :2744~2747.
  • 4[4]Moazed TC, Kuo CC, Grayston JT, et al. Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J Infec Dis, 1998, 177:1322~1325.
  • 5[5]Muhlestain JB, Hammond EH, Carlquist JF, et al. Increased incidence of chlamydia species with in the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol, 1996; 27: 1555~1561.
  • 6[6]Wang SP, Kuo CC, Grayston JT. Formalinized Chlamydia tra chomatis organisms as antigen in the micro - immunofluo reseence test. J Clin Microbiol, 1979, 10:259~261.
  • 7[7]Messmer TO, Martinez J, Hassouna F, et al. Comparison of two commercial microimmunofluorescence kits and an enzyme immunoassay kit for detection of serum immunoglobulin G anti bodies to Chlamydia pneumoniae. Clin Diagn Lab Immnuol,2001, 8(3) :588~592.
  • 8[8]Persson K, Boman J. Comparison of five serologic tests for diag nosis of acute infections by Chlamydia pneumoniae. Clin Diagn Lab Immnuol, 2000, 7(5);739~744.
  • 9[9]Verkooyen RP, Sijmons M, Fries E, et al. Widely used, com mercially available Chlamydia pneumoniae antigen contaminated with mycoplasma. J Med Microbiol, 1997, 46:419~424.
  • 10[10]Grayston JT. Chlamydia pneumoniae, stain TWAR. Chest,1989, 95:664~669.

同被引文献126

引证文献15

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部